Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study

BACKGROUND: In Canada, interferon-free, direct-acting antiviral hepatitis C virus (HCV) regimens are costly. This presents challenges for universal drug coverage of the estimated 220 000 people with chronic HCV infection nationwide. The study objective was to appraise criteria for reimbursement of 4...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CMAJ Open
Main Authors: Marshall, Alison D., Saeed, Sahar, Barrett, Lisa, Cooper, Curtis L., Treloar, Carla, Bruneau, Julie, Feld, Jordan J., Gallagher, Lesley, Klein, Marina B., Krajden, Mel, Shoukry, Naglaa H., Taylor, Lynn E., Grebely, Jason
Formato: Artigo
Idioma:Inglês
Publicado em: Joule Inc. or its licensors 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173474/
https://ncbi.nlm.nih.gov/pubmed/28018873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20160008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados